Booming Demand for Obesity Pill to Solve Junk Food Problem
Supposedly hundreds of thousands of Americans are lining up each week to get one of Pharma's hottest new injections.
STORY AT-A-GLANCE
The antiobesity injection Wegovy (semaglutide) has become so popular that, in early May 2023, Novo Nordisk announced it would cut the supply of starter doses for the U.S. market to “safeguard continuity of care” for existing patients
To maintain weight loss achieved on Wegovy, you must continue taking the drug indefinitely, or the weight…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.